Insider · CIK 0001950232
Andrew Reardon
officer
Files at LGND (LIGAND PHARMACEUTICALS INC). First filing Jun 2, 2025, latest Oct 6, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $4.2M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LGND: LIGAND PHARMACEUTICALS INC
LGNDOct 9, 2026 · close 301.81
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | LIGAND PHARMACEUTICALS INC | $1.5M 5,000 shares | -14% | +70% from low-6% from high | |
| 33Weak | LIGAND PHARMACEUTICALS INC | $1.4M 5,000 shares | -12% | - | |
| 25Weak | LIGAND PHARMACEUTICALS INC | $1.0M 5,000 shares | -12% | +116% from low-0% from high | |
| 22Weak | LGNDsell LIGAND PHARMACEUTICALS INC | $57k 500 shares | -2% | +19% from low-11% from high | |
| 22Weak | LGNDsell LIGAND PHARMACEUTICALS INC | $57k 500 shares | -2% | +17% from low-13% from high | |
| 25Weak | LGNDsell LIGAND PHARMACEUTICALS INC | $104k 1,000 shares | -3% | +7% from low-20% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +340 | $52.27 | $18k | 36,854 | 6 d ago |
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -833 | $302.51 | $252k | 36,021 | 6 d ago |
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -1,976 | $303.54 | $600k | 34,045 | 6 d ago |
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -1,535 | $304.52 | $467k | 32,510 | 6 d ago |
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -404 | $306.18 | $124k | 32,106 | 6 d ago |
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -235 | $307.19 | $72k | 31,871 | 6 d ago |
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -17 | $307.74 | $5,232 | 31,854 | 6 d ago |
| Oct 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -340 | $0.00 | $0 | 29,104 | 6 d ago |
| Sep 3, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -300 | $283.99 | $85k | 41,214 | 34 d ago |
| Sep 3, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -1,800 | $285.17 | $513k | 39,414 | 34 d ago |
| Sep 3, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -2,115 | $286.36 | $606k | 37,299 | 34 d ago |
| Sep 3, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -385 | $287.53 | $111k | 36,914 | 34 d ago |
| Sep 3, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -400 | $288.98 | $116k | 36,514 | 34 d ago |
| Mar 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Common Stock | +4,513 | $0.00 | $0 | 41,382 | Mar 27, 2026 |
| Mar 2, 2026 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right to buy)derivative | +21,525 | $0.00 | $0 | 21,525 | Mar 27, 2026 |
| Mar 4, 2026 | LGND LIGAND PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +5,000 | $52.27 | $261k | 41,869 | Mar 6, 2026 |
| Mar 4, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -100 | $197.70 | $20k | 41,769 | Mar 6, 2026 |
| Mar 4, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -100 | $199.01 | $20k | 41,669 | Mar 6, 2026 |
| Mar 4, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -207 | $199.96 | $41k | 41,462 | Mar 6, 2026 |
| Mar 4, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -93 | $200.62 | $19k | 41,369 | Mar 6, 2026 |
| Mar 4, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -300 | $201.70 | $61k | 41,069 | Mar 6, 2026 |
| Mar 4, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -200 | $204.17 | $41k | 40,869 | Mar 6, 2026 |
| Mar 4, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -460 | $205.18 | $94k | 40,409 | Mar 6, 2026 |
| Mar 4, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -340 | $206.37 | $70k | 40,069 | Mar 6, 2026 |
| Mar 4, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -612 | $207.01 | $127k | 39,457 | Mar 6, 2026 |
| Mar 4, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -1,446 | $208.12 | $301k | 38,011 | Mar 6, 2026 |
| Mar 4, 2026 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -1,142 | $208.87 | $239k | 36,869 | Mar 6, 2026 |
| Mar 4, 2026 | LGND LIGAND PHARMACEUTICALS INC | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 54,444 | Mar 6, 2026 |
| Feb 14, 2026 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Common Stock | +6,928 | $0.00 | $0 | 37,739 | Feb 18, 2026 |
| Feb 14, 2026 | LGND LIGAND PHARMACEUTICALS INC | FTax withholding Common Stock | -3,211 | $183.83 | $590k | 34,528 | Feb 18, 2026 |
| Feb 14, 2026 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Common Stock | +8,810 | $0.00 | $0 | 43,338 | Feb 18, 2026 |
| Feb 14, 2026 | LGND LIGAND PHARMACEUTICALS INC | FTax withholding Common Stock | -4,083 | $183.83 | $751k | 39,255 | Feb 18, 2026 |
| Feb 15, 2026 | LGND LIGAND PHARMACEUTICALS INC | FTax withholding Common Stock | -593 | $183.83 | $109k | 38,662 | Feb 18, 2026 |
| Feb 15, 2026 | LGND LIGAND PHARMACEUTICALS INC | FTax withholding Common Stock | -801 | $183.83 | $147k | 37,861 | Feb 18, 2026 |
| Feb 15, 2026 | LGND LIGAND PHARMACEUTICALS INC | FTax withholding Common Stock | -992 | $183.83 | $182k | 36,869 | Feb 18, 2026 |
| Aug 10, 2025 | LGND LIGAND PHARMACEUTICALS INC | FTax withholding Common Stock | -1,325 | $150.06 | $199k | 30,811 | Aug 12, 2025 |
| Jun 30, 2025 | LGND LIGAND PHARMACEUTICALS INC | JOther Common Stock | +233 | $91.08 | $21k | 32,136 | Jul 2, 2025 |
| Jun 23, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock | -500 | $114.08 | $57k | 31,903 | Jun 24, 2025 |
| Jun 10, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock | -500 | $114.54 | $57k | 32,403 | Jun 12, 2025 |
| Aug 10, 2024 | LGND LIGAND PHARMACEUTICALS INC | FTax withholding Common Stock | -897 | $100.16 | $90k | 21,637 | Jun 2, 2025 |
| May 15, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock | -1,000 | $104.00 | $104k | 32,903 | Jun 2, 2025 |
| Mar 4, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Common Stock | +6,415 | $0.00 | $0 | 34,783 | Mar 6, 2025 |
| Mar 4, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Employee Stock Option (right to buy)derivative | +28,043 | $0.00 | $0 | 28,043 | Mar 6, 2025 |
| Feb 14, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Common Stock | +6,928 | $0.00 | $0 | 29,462 | Feb 19, 2025 |
| Feb 14, 2025 | LGND LIGAND PHARMACEUTICALS INC | FTax withholding Common Stock | -2,775 | $120.00 | $333k | 26,687 | Feb 19, 2025 |
| Feb 14, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Common Stock | +5,429 | $0.00 | $0 | 32,116 | Feb 19, 2025 |
| Feb 14, 2025 | LGND LIGAND PHARMACEUTICALS INC | FTax withholding Common Stock | -1,758 | $120.00 | $211k | 30,358 | Feb 19, 2025 |
| Feb 15, 2025 | LGND LIGAND PHARMACEUTICALS INC | FTax withholding Common Stock | -1,114 | $120.00 | $134k | 29,244 | Feb 19, 2025 |
| Feb 15, 2025 | LGND LIGAND PHARMACEUTICALS INC | FTax withholding Common Stock | -876 | $120.00 | $105k | 28,368 | Feb 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.